Lintuzumab (Anti-Siglec-3 / CD33)
Lintuzumab (HuM195) is a humanized monoclonal antibody that targets CD33, a 67-kDa cell surface glycoprotein expressed on most myeloid leukemia cells. MW: 145. 24 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2760 |
| Sku # | A2760-1mg*25 |
| Pricing | 1mg*25, $5070.00 |